These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 24695356

  • 1. Measurement of the direct oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in human plasma using turbulent flow liquid chromatography with high-resolution mass spectrometry.
    Gous T, Couchman L, Patel JP, Paradzai C, Arya R, Flanagan RJ.
    Ther Drug Monit; 2014 Oct; 36(5):597-605. PubMed ID: 24695356
    [Abstract] [Full Text] [Related]

  • 2. Paramagnetic micro-particles as a tool for rapid quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma by UHPLC-MS/MS.
    Wiesen MHJ, Blaich C, Streichert T, Michels G, Müller C.
    Clin Chem Lab Med; 2017 Aug 28; 55(9):1349-1359. PubMed ID: 28328524
    [Abstract] [Full Text] [Related]

  • 3. Quantification of Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in Human Serum by UHPLC-MS/MS-Method Development, Validation, and Application.
    Lindahl S, Dyrkorn R, Spigset O, Hegstad S.
    Ther Drug Monit; 2018 Jun 28; 40(3):369-376. PubMed ID: 29578938
    [Abstract] [Full Text] [Related]

  • 4. Measurement of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma using automated online solid-phase extraction combined with ultra-performance liquid chromatography-tandem mass spectrometry and its comparison with coagulation assays.
    Kuhn J, Gripp T, Flieder T, Hammerschmidt A, Hendig D, Faust I, Knabbe C, Birschmann I.
    Clin Chim Acta; 2018 Nov 28; 486():347-356. PubMed ID: 30114406
    [No Abstract] [Full Text] [Related]

  • 5. Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants.
    Schmitz EM, Boonen K, van den Heuvel DJ, van Dongen JL, Schellings MW, Emmen JM, van der Graaf F, Brunsveld L, van de Kerkhof D.
    J Thromb Haemost; 2014 Oct 28; 12(10):1636-46. PubMed ID: 25142183
    [Abstract] [Full Text] [Related]

  • 6. A simple and fast HPLC-MS/MS method for simultaneous determination of direct oral anticoagulants apixaban, dabigatran, rivaroxaban in human plasma.
    Lagoutte-Renosi J, Le Poupon J, Girard A, Montange D, Davani S.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Nov 15; 1100-1101():43-49. PubMed ID: 30292948
    [Abstract] [Full Text] [Related]

  • 7. Direct oral anticoagulants--pharmacology, drug interactions, and side effects.
    Dempfle CE.
    Semin Hematol; 2014 Apr 15; 51(2):89-97. PubMed ID: 24861792
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the in vitro stability of direct oral anticoagulants in blood samples under different storage conditions.
    Thuile K, Giacomuzzi K, Jani E, Marschang P, Mueller T.
    Scand J Clin Lab Invest; 2021 Oct 15; 81(6):461-468. PubMed ID: 34278897
    [Abstract] [Full Text] [Related]

  • 9. A UHPLC-MS/MS method to simultaneously quantify apixaban, edoxaban and rivaroxaban in human plasma and breast milk: For emerging lactation studies.
    Zhao Y, Couchman L, Kipper K, Arya R, Patel JP.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May 01; 1144():122095. PubMed ID: 32251991
    [Abstract] [Full Text] [Related]

  • 10. Quantitation of the Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Warfarin in Plasma Using Ultra-Performance Liquid Chromatography with Tandem Mass Spectrometry (UPLC-MS/MS).
    Noguez JH, Ritchie JC.
    Methods Mol Biol; 2016 May 01; 1383():21-7. PubMed ID: 26660170
    [Abstract] [Full Text] [Related]

  • 11. Development, validation and application of a new HPLC-DAD method for simultaneous quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma.
    Gouveia F, Bicker J, Santos J, Rocha M, Alves G, Falcão A, Fortuna A.
    J Pharm Biomed Anal; 2020 Mar 20; 181():113109. PubMed ID: 31981828
    [Abstract] [Full Text] [Related]

  • 12. Determination of rivaroxaban, apixaban and edoxaban in rat plasma by UPLC-MS/MS method.
    Zhang WL, Lou D, Zhang DT, Zhang Y, Huang HJ.
    J Thromb Thrombolysis; 2016 Aug 20; 42(2):205-11. PubMed ID: 27116356
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Simultaneous Determination of Dabigatran, Rivaroxaban, and Apixaban in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry.
    Zhang M, Moore GA, Chin PKL.
    Ther Drug Monit; 2020 Jun 20; 42(3):473-480. PubMed ID: 32053549
    [Abstract] [Full Text] [Related]

  • 15. New oral anticoagulants for the treatment of venous thromboembolism.
    Agnelli G, Becattini C, Franco L.
    Best Pract Res Clin Haematol; 2013 Jun 20; 26(2):151-61. PubMed ID: 23953903
    [Abstract] [Full Text] [Related]

  • 16. Multi-analyte analysis of non-vitamin K antagonist oral anticoagulants in human plasma using tandem mass spectrometry.
    Blaich C, Müller C, Michels G, Wiesen MH.
    Clin Chem Lab Med; 2015 Nov 20; 53(12):1981-90. PubMed ID: 25901716
    [Abstract] [Full Text] [Related]

  • 17. Simultaneous determination of rivaroxaban and dabigatran levels in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
    Korostelev M, Bihan K, Ferreol L, Tissot N, Hulot JS, Funck-Brentano C, Zahr N.
    J Pharm Biomed Anal; 2014 Nov 20; 100():230-235. PubMed ID: 25173108
    [Abstract] [Full Text] [Related]

  • 18. Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.
    Prescrire Int; 2013 Jun 20; 22(139):155-9. PubMed ID: 23866358
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term benefits of preventing venous thromboembolic events.
    Cohen AT.
    Curr Med Res Opin; 2012 Jun 20; 28(6):877-89. PubMed ID: 22533680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.